Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Mayinglong Pharmaceutical Group Co Ltd
Gross Profit
Mayinglong Pharmaceutical Group Co Ltd
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
|
Gross Profit
¥1.5B
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Gross Profit
¥9.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Gross Profit
¥4.4B
|
CAGR 3-Years
15%
|
CAGR 5-Years
18%
|
CAGR 10-Years
20%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Gross Profit
¥18.7B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
15%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Gross Profit
¥10.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Gross Profit
¥1.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
See Also
What is Mayinglong Pharmaceutical Group Co Ltd's Gross Profit?
Gross Profit
1.5B
CNY
Based on the financial report for Sep 30, 2023, Mayinglong Pharmaceutical Group Co Ltd's Gross Profit amounts to 1.5B CNY.
What is Mayinglong Pharmaceutical Group Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
8%
Over the last year, the Gross Profit growth was 3%. The average annual Gross Profit growth rates for Mayinglong Pharmaceutical Group Co Ltd have been 11% over the past three years , 9% over the past five years , and 8% over the past ten years .